Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gordon

Showing results (471-480 of 473) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 473 results.
European Journal of Nuclear Medicine and Molecular Imaging|September 30, 2020
Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [<sup>18</sup>F] fluspidine and [<sup>18</sup>F] fallypride PET studyIgor D Grachev, Philipp M Meyer, Georg A Becker, et al.
BMC Geriatrics|November 28, 2018
Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ studyNienke Legdeur, Maryam Badissi, Stephen F Carter, et al.
Alzheimer'S Research & Therapy|September 29, 2018
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery studyMara Ten Kate, Alberto Redolfi, Enrico Peira, et al.
Pageof 48

Showing results (471-480 of 473) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 473 results.
European Journal of Nuclear Medicine and Molecular Imaging|September 30, 2020
Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [<sup>18</sup>F] fluspidine and [<sup>18</sup>F] fallypride PET studyIgor D Grachev, Philipp M Meyer, Georg A Becker, et al.
BMC Geriatrics|November 28, 2018
Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ studyNienke Legdeur, Maryam Badissi, Stephen F Carter, et al.
Alzheimer'S Research & Therapy|September 29, 2018
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery studyMara Ten Kate, Alberto Redolfi, Enrico Peira, et al.
Pageof 48